Marketing of a product, potassium iodide capsules of 65 mg equivalent to 50 mg iodine, which does not have a Marketing Authorization issued by NAMMDR. Action taken/proposed by the NCA: Suspension of the manufacturing authorisation No. 56F in Full Withdrawal, of current valid GMP certificate No. 009/2018/RO withdrawal of current valid GMP Certificate no.009/2018/RO
Inspection Record
Biogalenica Project & Consulting S.R.L. — EU GMP NCR (EudraGMDP) Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
1Other quality system
About this record
Extracted automatically from the document EMA (Europe) published on 2023-03-22. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
